SerpinB3/B4: mediators of Ras-driven inflammation and oncogenesis.
作者信息
Catanzaro Joseph M, Sheshadri Namratha, Zong Wei-Xing
机构信息
a Department of Molecular Genetics and Microbiology ; Stony Brook University ; Stony Brook ; NY USA.
出版信息
Cell Cycle. 2014;13(20):3155-6. doi: 10.4161/15384101.2014.969991.
Abstract
摘要
相似文献
1
SerpinB3/B4: mediators of Ras-driven inflammation and oncogenesis.丝氨酸蛋白酶抑制剂B3/B4：Ras驱动的炎症和肿瘤发生的介质
Cell Cycle. 2014;13(20):3155-6. doi: 10.4161/15384101.2014.969991.
2
Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4.致癌性Ras通过上调鳞状细胞癌抗原SerpinB3/B4来诱导炎性细胞因子的产生。
Nat Commun. 2014 Apr 23;5:3729. doi: 10.1038/ncomms4729.
3
SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy.丝氨酸蛋白酶抑制剂 B3 在接受新辅助化疗的乳腺癌患者中的预后价值。
Breast Cancer Res Treat. 2012 Apr;132(3):807-18. doi: 10.1007/s10549-011-1625-9. Epub 2011 Jun 22.
4
SERPINB3/B4 contributes to early inflammation and barrier dysfunction in an experimental murine model of atopic dermatitis.丝氨酸蛋白酶抑制剂B3/B4在特应性皮炎实验小鼠模型中导致早期炎症和屏障功能障碍。
J Invest Dermatol. 2015 Jan;135(1):160-169. doi: 10.1038/jid.2014.353. Epub 2014 Aug 11.
5
Role of SERPINB3 in hepatocellular carcinoma.丝氨酸蛋白酶抑制剂B3（SERPINB3）在肝细胞癌中的作用。
Ann Hepatol. 2014 Nov-Dec;13(6):722-7.
6
Tissue specific expression and estrogen regulation of SERPINB3 in the chicken oviduct.鸡输卵管组织特异性表达和雌激素调控丝氨酸蛋白酶抑制剂 B3。
Gen Comp Endocrinol. 2012 Jan 1;175(1):65-73. doi: 10.1016/j.ygcen.2011.09.019. Epub 2011 Oct 17.
7
SERPINB3 is associated with TGF-β1 and cytoplasmic β-catenin expression in hepatocellular carcinomas with poor prognosis.丝氨酸蛋白酶抑制剂 3（SERPINB3）与预后不良的肝细胞癌中 TGF-β1 和细胞质 β-连环蛋白的表达相关。
Br J Cancer. 2014 May 27;110(11):2708-15. doi: 10.1038/bjc.2014.246. Epub 2014 May 8.
8
SerpinB3 induces dipeptidyl-peptidase IV/CD26 expression and its metabolic effects in hepatocellular carcinoma.丝氨酸蛋白酶抑制剂 B3 诱导肝癌中二肽基肽酶 IV/CD26 的表达及其代谢作用。
Life Sci. 2018 May 1;200:134-141. doi: 10.1016/j.lfs.2018.03.014. Epub 2018 Mar 7.
9
The molecular signature of impaired diabetic wound healing identifies serpinB3 as a healing biomarker.糖尿病伤口愈合受损的分子特征将丝氨酸蛋白酶抑制剂B3鉴定为一种愈合生物标志物。
Diabetologia. 2014 Sep;57(9):1947-56. doi: 10.1007/s00125-014-3300-2. Epub 2014 Jun 25.
10
SERPINB3 expression on B-cell surface in autoimmune diseases and hepatitis C virus-related chronic liver infection.在自身免疫性疾病和丙型肝炎病毒相关慢性肝脏感染中，B 细胞表面的丝氨酸蛋白酶抑制剂 B3 表达。
Exp Biol Med (Maywood). 2012 Jul;237(7):793-802. doi: 10.1258/ebm.2012.012024. Epub 2012 Jul 24.
引用本文的文献
1
SerpinB3: A Multifaceted Player in Health and Disease-Review and Future Perspectives.丝氨酸蛋白酶抑制剂B3：健康与疾病中的多面角色——综述与未来展望
Cancers (Basel). 2024 Jul 18;16(14):2579. doi: 10.3390/cancers16142579.
2
SerpinB3/4 Expression Is Associated with Poor Prognosis in Patients with Cholangiocarcinoma.丝氨酸蛋白酶抑制剂B3/4表达与胆管癌患者的不良预后相关。
Cancers (Basel). 2024 Jan 3;16(1):225. doi: 10.3390/cancers16010225.
3
SerpinB3 as hepatic marker of post-resective shear stress.SerpinB3 作为肝切除术后切应力的肝标志物。
Updates Surg. 2023 Sep;75(6):1541-1548. doi: 10.1007/s13304-023-01531-6. Epub 2023 May 19.
4
SerpinB3 Differently Up-Regulates Hypoxia Inducible Factors -1α and -2α in Hepatocellular Carcinoma: Mechanisms Revealing Novel Potential Therapeutic Targets.丝氨酸蛋白酶抑制剂B3在肝细胞癌中对缺氧诱导因子-1α和-2α的上调作用不同：揭示新潜在治疗靶点的机制
Cancers (Basel). 2019 Dec 4;11(12):1933. doi: 10.3390/cancers11121933.
5
Identification of co-expression modules and pathways correlated with osteosarcoma and its metastasis.鉴定与骨肉瘤及其转移相关的共表达模块和途径。
World J Surg Oncol. 2019 Mar 8;17(1):46. doi: 10.1186/s12957-019-1587-7.
本文引用的文献
1
Oncogenic Ras induces inflammatory cytokine production by upregulating the squamous cell carcinoma antigens SerpinB3/B4.致癌性Ras通过上调鳞状细胞癌抗原SerpinB3/B4来诱导炎性细胞因子的产生。
Nat Commun. 2014 Apr 23;5:3729. doi: 10.1038/ncomms4729.
2
Over-expression of SERPINB3 in hepatoblastoma: a possible insight into the genesis of this tumour?肝母细胞瘤中 SERPINB3 的过度表达：这种肿瘤发生的可能机制？
Eur J Cancer. 2012 May;48(8):1219-26. doi: 10.1016/j.ejca.2011.06.004. Epub 2011 Jul 5.
3
SerpinB3, a new prognostic tool in breast cancer patients treated with neoadjuvant chemotherapy.丝氨酸蛋白酶抑制剂 B3 在接受新辅助化疗的乳腺癌患者中的预后价值。
Breast Cancer Res Treat. 2012 Apr;132(3):807-18. doi: 10.1007/s10549-011-1625-9. Epub 2011 Jun 22.
4
Elevated expression of squamous cell carcinoma antigen (SCCA) is associated with human breast carcinoma.鳞状细胞癌抗原（SCCA）的高表达与人类乳腺癌有关。
PLoS One. 2011 Apr 19;6(4):e19096. doi: 10.1371/journal.pone.0019096.
5
Cross-class inhibition of the cysteine proteinases cathepsins K, L, and S by the serpin squamous cell carcinoma antigen 1: a kinetic analysis.丝氨酸蛋白酶抑制剂鳞状细胞癌抗原1对半胱氨酸蛋白酶组织蛋白酶K、L和S的交叉抑制作用：动力学分析
Biochemistry. 1998 Apr 14;37(15):5258-66. doi: 10.1021/bi972521d.
6
Radioimmunoassay for tumor antigen of human cervical squamous cell carcinoma.
Cancer. 1977 Oct;40(4):1621-8. doi: 10.1002/1097-0142(197710)40:4<1621::aid-cncr2820400435>3.0.co;2-i.
Zotero 插件